Pfizer Declares 32-Cent Third-Quarter 2017 Dividend
June 22 2017 - 4:05PM
Business Wire
The board of directors of Pfizer Inc. today declared a 32-cent
third-quarter 2017 dividend on the company’s common stock, payable
September 1, 2017, to shareholders of record at the close of
business on August 4, 2017. The third-quarter 2017 cash dividend
will be the 315th consecutive quarterly dividend paid by
Pfizer.
Working together for a healthier
world®
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products. Our global portfolio includes medicines and vaccines as
well as many of the world's best-known consumer health care
products. Every day, Pfizer colleagues work across developed and
emerging markets to advance wellness, prevention, treatments and
cures that challenge the most feared diseases of our time.
Consistent with our responsibility as one of the world's premier
innovative biopharmaceutical companies, we collaborate with health
care providers, governments and local communities to support and
expand access to reliable, affordable health care around the world.
For more than 150 years, we have worked to make a difference for
all who rely on us. We routinely post information that may be
important to investors on our website at www.pfizer.com. In
addition, to learn more, please visit us on www.pfizer.com and
follow us on Twitter at @Pfizer and @Pfizer_News, LinkedIn, YouTube
and like us on Facebook at Facebook.com/Pfizer.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170622006123/en/
Pfizer Inc.Media:Joan Campion, 212-733-2798orInvestors:Ryan
Crowe, 212-733-8160
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2024 to May 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From May 2023 to May 2024